NO20002789L - Hydrofobisk-modifiserte proteinpreparater og fremgangsmater for fremstilling derav - Google Patents
Hydrofobisk-modifiserte proteinpreparater og fremgangsmater for fremstilling deravInfo
- Publication number
- NO20002789L NO20002789L NO20002789A NO20002789A NO20002789L NO 20002789 L NO20002789 L NO 20002789L NO 20002789 A NO20002789 A NO 20002789A NO 20002789 A NO20002789 A NO 20002789A NO 20002789 L NO20002789 L NO 20002789L
- Authority
- NO
- Norway
- Prior art keywords
- protein
- methods
- preparation
- hydrophobically modified
- modified protein
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title 2
- 102000035118 modified proteins Human genes 0.000 title 1
- 108091005573 modified proteins Proteins 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 abstract 5
- 102000004169 proteins and genes Human genes 0.000 abstract 5
- 230000002209 hydrophobic effect Effects 0.000 abstract 4
- 241000051107 Paraechinus aethiopicus Species 0.000 abstract 1
- 125000000539 amino acid group Chemical group 0.000 abstract 1
- 210000000170 cell membrane Anatomy 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 239000002502 liposome Substances 0.000 abstract 1
- 239000000693 micelle Substances 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Marine Sciences & Fisheries (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Graft Or Block Polymers (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6742397P | 1997-12-03 | 1997-12-03 | |
| US7893598P | 1998-03-20 | 1998-03-20 | |
| US8968598P | 1998-06-17 | 1998-06-17 | |
| US9980098P | 1998-09-10 | 1998-09-10 | |
| PCT/US1998/025676 WO1999028343A2 (en) | 1997-12-03 | 1998-12-03 | Hydrophobically-modified protein compositions and methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20002789D0 NO20002789D0 (no) | 2000-05-31 |
| NO20002789L true NO20002789L (no) | 2000-08-02 |
Family
ID=27490628
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20002789A NO20002789L (no) | 1997-12-03 | 2000-05-31 | Hydrofobisk-modifiserte proteinpreparater og fremgangsmater for fremstilling derav |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US6444793B1 (pl) |
| EP (1) | EP1036092B1 (pl) |
| JP (1) | JP4289788B2 (pl) |
| KR (1) | KR20010032753A (pl) |
| CN (1) | CN1294595A (pl) |
| AT (1) | ATE295372T1 (pl) |
| AU (1) | AU757497B2 (pl) |
| BR (1) | BR9815142A (pl) |
| CA (1) | CA2309806A1 (pl) |
| CZ (1) | CZ20002008A3 (pl) |
| DE (1) | DE69830192T2 (pl) |
| DK (1) | DK1036092T3 (pl) |
| EA (1) | EA003739B1 (pl) |
| EE (1) | EE200000308A (pl) |
| ES (1) | ES2243018T3 (pl) |
| HU (1) | HUP0100535A3 (pl) |
| IL (2) | IL136137A0 (pl) |
| IS (1) | IS2163B (pl) |
| MX (1) | MXPA00005494A (pl) |
| NO (1) | NO20002789L (pl) |
| NZ (1) | NZ504752A (pl) |
| PL (1) | PL197833B1 (pl) |
| PT (1) | PT1036092E (pl) |
| TR (1) | TR200001612T2 (pl) |
| WO (1) | WO1999028343A2 (pl) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1034269A1 (en) * | 1997-11-28 | 2000-09-13 | Roche Diagnostics GmbH | An active hedgehog-protein-mutant, a process for its preparation and its use for pharmaceutical purposes |
| KR20010032753A (ko) | 1997-12-03 | 2001-04-25 | 온토제니, 인코오포레이티드 | 소수적으로 개질된 단백질 조성물 및 방법 |
| US6897297B1 (en) * | 1997-12-03 | 2005-05-24 | Curis, Inc. | Hydrophobically-modified protein compositions and methods |
| EP0953576B1 (en) * | 1998-04-30 | 2005-11-02 | Curis, Inc. | Active hedgehog protein conjugate, process for its production and use |
| TW570805B (en) | 1998-09-01 | 2004-01-11 | Hoffmann La Roche | Water-soluble pharmaceutical composition in an ionic complex |
| ATE404583T1 (de) * | 1998-11-02 | 2008-08-15 | Curis Inc | Funktionelle antagonisten von hedgehog-aktivität |
| IL143403A0 (en) * | 1998-12-03 | 2002-04-21 | Biogen Inc | Methods and compositions for treating disorders involving excitotoxicity |
| EP1025861A1 (de) * | 1999-02-04 | 2000-08-09 | Roche Diagnostics GmbH | Pharmazeutische Zusammensetzung von hydrophob modifizierten Hedgehog-Proteinen und deren Verwendung |
| JP2003502292A (ja) * | 1999-06-01 | 2003-01-21 | バイオジェン インコーポレイテッド | ヘッジホッグタンパク質のポリマー結合体及び利用 |
| AU2005203058C1 (en) * | 1999-11-05 | 2009-07-02 | Curis, Inc. | Hedgehog fusion proteins and uses |
| AU780693B2 (en) * | 1999-11-05 | 2005-04-14 | Curis, Inc. | Hedgehog fusion proteins and uses |
| WO2001082994A1 (en) * | 2000-04-28 | 2001-11-08 | Curis, Inc. | Methods and reagents for tissue engineering of cartilage in vitro |
| AU2003225085A1 (en) * | 2002-04-19 | 2003-11-03 | California Institute Of Technology | Unnatural amino acid containing display libraries |
| JP2008506703A (ja) | 2004-07-14 | 2008-03-06 | ユニバーシティ オブ ユタ リサーチ ファウンデーション | ネトリン関連化合物および用途 |
| WO2006101273A1 (ja) * | 2005-03-25 | 2006-09-28 | Takeda Pharmaceutical Company Limited | 癌の予防・治療剤 |
| AU2006313464B2 (en) * | 2005-11-11 | 2012-07-12 | Proteogen Bio S.R.L. | Method of converting water-soluble active proteins into hydrophobic active proteins, the use of the same for the preparation of monomolecular layers of oriented active proteins, and devices comprising the same |
| US8273747B2 (en) | 2006-11-02 | 2012-09-25 | Curis, Inc. | Small organic molecule regulators of cell proliferation |
| KR100876657B1 (ko) * | 2007-10-15 | 2009-01-07 | 한국기계연구원 | 표면개질된 마이크로비드와 마이크로비드 어레이칩의제조방법과 마이크로비드 어레이칩을 이용한 질병특이항원의 확인방법 |
| CN101952306B (zh) * | 2008-02-21 | 2014-09-10 | 皮护神经科学协会 | Mntf肽的化妆和皮肤病制剂 |
| US20100316566A1 (en) * | 2008-02-27 | 2010-12-16 | Radiomedix Inc. | Radiolabeled hedgehog derivatives for imaging and therapy |
| UA107571C2 (xx) * | 2009-04-03 | 2015-01-26 | Фармацевтична композиція | |
| CN103665095A (zh) * | 2012-09-11 | 2014-03-26 | 中国人民解放军军事医学科学院卫生学环境医学研究所 | 一种疏水性多肽修饰抗体的合成方法 |
| CN106924754B (zh) * | 2015-12-30 | 2021-11-09 | 北京大学 | 聚氨基酸偶联物 |
| CN108147990B (zh) * | 2016-12-02 | 2023-01-24 | 上海中医药大学 | 一种膜锚定元件及其应用 |
| KR102710762B1 (ko) | 2017-10-25 | 2024-09-25 | 얀센 파마슈티칼즈, 인코포레이티드 | 인산화 타우 펩티드의 조성물 및 이의 용도 |
| AU2020219804A1 (en) | 2019-02-08 | 2021-08-19 | Ac Immune S.A. | Method of safe administration of phosphorylated Tau peptide vaccine |
| JP2023136614A (ja) * | 2022-03-17 | 2023-09-29 | 三菱ケミカル株式会社 | 植物を用いたヘッジホッグタンパク質の製造方法 |
| CN116983461B (zh) * | 2023-03-14 | 2025-07-22 | 中国石油大学(华东) | 基于脂质体修饰的止血海绵体系 |
| CN116549713B (zh) * | 2023-05-09 | 2025-06-13 | 浙江大学 | 一种兼具组织粘合和防粘连的手术贴片和其制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5374548A (en) * | 1986-05-02 | 1994-12-20 | Genentech, Inc. | Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor |
| US5399347A (en) | 1987-06-24 | 1995-03-21 | Autoimmune, Inc. | Method of treating rheumatoid arthritis with type II collagen |
| US5409611A (en) * | 1988-03-24 | 1995-04-25 | Terrapin Technoogies, Inc. | Method to identify analyte-binding ligands |
| US5130297A (en) | 1988-06-23 | 1992-07-14 | Anergen, Inc. | Conjugates useful in ameliorating autoimmunity MHC-II-peptide |
| US5824315A (en) * | 1993-10-25 | 1998-10-20 | Anergen, Inc. | Binding affinity of antigenic peptides for MHC molecules |
| US6281332B1 (en) * | 1994-12-02 | 2001-08-28 | The Johns Hopkins University School Of Medicine | Hedgehog-derived polypeptides |
| US5869602A (en) * | 1995-03-17 | 1999-02-09 | Novo Nordisk A/S | Peptide derivatives |
| EP0966478A4 (en) * | 1996-10-07 | 2002-08-21 | Univ Johns Hopkins Med | Novel hedgehog-derived polypeptides |
| KR20010032753A (ko) | 1997-12-03 | 2001-04-25 | 온토제니, 인코오포레이티드 | 소수적으로 개질된 단백질 조성물 및 방법 |
-
1998
- 1998-12-03 KR KR1020007006044A patent/KR20010032753A/ko not_active Withdrawn
- 1998-12-03 WO PCT/US1998/025676 patent/WO1999028343A2/en not_active Ceased
- 1998-12-03 DK DK98964702T patent/DK1036092T3/da active
- 1998-12-03 PT PT98964702T patent/PT1036092E/pt unknown
- 1998-12-03 EA EA200000605A patent/EA003739B1/ru not_active IP Right Cessation
- 1998-12-03 EP EP98964702A patent/EP1036092B1/en not_active Expired - Lifetime
- 1998-12-03 PL PL341430A patent/PL197833B1/pl not_active IP Right Cessation
- 1998-12-03 CZ CZ20002008A patent/CZ20002008A3/cs unknown
- 1998-12-03 IL IL13613798A patent/IL136137A0/xx unknown
- 1998-12-03 NZ NZ504752A patent/NZ504752A/xx not_active IP Right Cessation
- 1998-12-03 AU AU19966/99A patent/AU757497B2/en not_active Ceased
- 1998-12-03 CA CA002309806A patent/CA2309806A1/en not_active Abandoned
- 1998-12-03 ES ES98964702T patent/ES2243018T3/es not_active Expired - Lifetime
- 1998-12-03 TR TR2000/01612T patent/TR200001612T2/xx unknown
- 1998-12-03 MX MXPA00005494A patent/MXPA00005494A/es active IP Right Grant
- 1998-12-03 CN CN98813447A patent/CN1294595A/zh active Pending
- 1998-12-03 BR BR9815142-8A patent/BR9815142A/pt not_active Application Discontinuation
- 1998-12-03 AT AT98964702T patent/ATE295372T1/de not_active IP Right Cessation
- 1998-12-03 EE EEP200000308A patent/EE200000308A/xx unknown
- 1998-12-03 DE DE69830192T patent/DE69830192T2/de not_active Expired - Lifetime
- 1998-12-03 JP JP2000523234A patent/JP4289788B2/ja not_active Expired - Lifetime
- 1998-12-03 HU HU0100535A patent/HUP0100535A3/hu unknown
-
1999
- 1999-06-03 US US09/325,256 patent/US6444793B1/en not_active Expired - Lifetime
-
2000
- 2000-05-14 IL IL136137A patent/IL136137A/en active IP Right Grant
- 2000-05-15 IS IS5499A patent/IS2163B/is unknown
- 2000-05-31 NO NO20002789A patent/NO20002789L/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20002789L (no) | Hydrofobisk-modifiserte proteinpreparater og fremgangsmater for fremstilling derav | |
| Hou et al. | Peptidyl N, N-bis (2-mercaptoethyl)-amides as thioester precursors for native chemical ligation | |
| ATE330224T1 (de) | Funktionelles protein array | |
| EP1067182A3 (en) | Secretory protein or membrane protein | |
| KR870001237A (ko) | 혈액응고 억제작용을 갖는 폴리펩티드의 분리 및 제조 방법 | |
| ATE431834T1 (de) | Prozess zur trennung von proteinen | |
| IL115199A (en) | Composition comprising a polynucleic acid molecule in a liposome and method using said composition | |
| WO2004058946A3 (en) | Protein arrays | |
| DE60144145D1 (de) | Subtilisin-variante | |
| AR004860A1 (es) | Anticuerpos mono o policionales, anticuerpos conjugados, o sus fragmentos, su utilizacion y metodo de diagnostico in vitro de patologias correlacionadas con una expresion anormal del receptor de la il-13, a partir de muestras biologicas susceptibles de contener el receptor de la il-13 expresado a un nivel anormal | |
| BR9811675A (pt) | Genes isolados para proteìna da membrana de célula dentrìtica | |
| WO1996038553A1 (en) | A method for identification of biologically active peptides and nucleic acids | |
| WO2000000600A3 (en) | Lentiviral vectors, comprising modified major donor splice sites and major packaging signals | |
| JP2004535152A (ja) | 細胞培養物に対する成長影響活性を有するカゼインペプチドフラグメント | |
| ATE46703T1 (de) | Regionspezifische determinanten fuer vitamin-k abhaengiges knochenprotein. | |
| Slaughter et al. | Demonstration that bovine erythrocyte cytochrome b5 is the hydrophilic segment of liver microsomal cytochrome b5 | |
| NO984491L (no) | SCF-analogpreparater og fremgangsmÕte for fremstilling av disse | |
| BR9714133A (pt) | ácido nucleico isolado, molécula do mesmo, sonda, vetor de expressão recombinante, célula, polipeptìdeo, proteìna de fusão formulação de vacina e processos para produzir um polipeptìdeo de h. pylori, para detctar a presença de um ácido nucleico de helicobacter em uma amostra, para tratar ou reduzir um risco de infecção por h. pylori em um indivìduo e para produzir uma formulação de vacina | |
| Gahmberg et al. | Cell surface proteins: changes during cell growth and malignant transformation | |
| WO1999028876A3 (en) | Hydrophobically-modified protein compositions and methods | |
| Ogishima et al. | Partial amino acid sequences of two mitochondrial and two microsomal cytochrome P-450's from adrenal cortex | |
| WO1999047673A3 (en) | Isolated mammalian membrane protein genes and related reagents | |
| CY1105486T1 (el) | Τροποποιημενες υδροφοβικα συνθεσεις πρωτεϊνων ακανθοχοιρου και μεθοδοι παρασκευης αυτων | |
| BR0213772A (pt) | Molécula de ácido nucleico isolada, vetor, célula hospedeira, e, método para a preparação de um composto de quìmica fina | |
| WO2000032746A3 (en) | Netrin-like and ependymin-like nucleic acids and polypeptides and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |